rs1554301854
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_000426.4(LAMA2):c.7156-5_7157delAATAGAGinsT(p.Arg2386fs) variant causes a frameshift, splice acceptor, splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. R2386?) has been classified as Pathogenic. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000426.4 frameshift, splice_acceptor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMA2 | NM_000426.4 | c.7156-5_7157delAATAGAGinsT | p.Arg2386fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | 51/65 | ENST00000421865.3 | NP_000417.3 | |
LAMA2 | NM_001079823.2 | c.7156-5_7157delAATAGAGinsT | p.Arg2386fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | 51/64 | NP_001073291.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMA2 | ENST00000421865.3 | c.7156-5_7157delAATAGAGinsT | p.Arg2386fs | frameshift_variant, splice_acceptor_variant, splice_region_variant, intron_variant | 51/65 | 5 | NM_000426.4 | ENSP00000400365.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
LAMA2-related muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 03, 2016 | For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (ExAC no frequency). While this particular variant has not been reported in the literature, truncating variants in LAMA2 are known to be pathogenic (PMID: 18700894). This variant, c.7156-5_7157delAATAGAGinsT, is a complex sequence change at the junction of intron 50 and exon 51 of the LAMA2 gene. The terminal 5 nucleotides of intron 50 and the first 2 nucleotides of exon 51 are deleted and replaced by a single T nucleotide.  This sequence change affects an acceptor splice site in intron 50 of the LAMA2 gene. It is expected to disrupt mRNA splicing or cause a frameshift and likely results in an absent or disrupted protein product. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at